Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazarotene in Early-Stage CTCL
NCT00779896Phase 2Unknown
- Sponsor
- McGill University
- Start
- Oct 2008
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tazarotene in cutaneous T-cell lymphoma (CTCL), sponsored by McGill University. Status: unknown.
02
Drugs
tazarotene
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00779896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779896.